Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PALIFE trial of oral paricalcitol in chronic proteinuric kidney disease
2011-002877-46Phase 4Terminated
- Sponsor
- Fundación Renal Española
- Start
- Oct 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of paricalcitol in chronic kidney disease (CKD) and proteinuria (2 arms), sponsored by Fundación Renal Española. Primary endpoint: Change in albuminuria by UACR. Started Oct 2011; status: terminated.
02
Drugs
paricalcitol
03
Conditions
chronic kidney disease (CKD)proteinuria
Beyond the preview
Go deeper on 2011-002877-46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002877-46.